Unique ID issued by UMIN | UMIN000013167 |
---|---|
Receipt number | R000015354 |
Scientific Title | A randomized controlled trial for improving effects of "KIMIE WHITE" or "CYSTATHIONE" on skins in women |
Date of disclosure of the study information | 2014/02/14 |
Last modified on | 2017/01/30 18:29:36 |
A randomized controlled trial for improving effects of "KIMIE WHITE" or "CYSTATHIONE" on skins in women
A randomized controlled trial for improving effects on skins in women
A randomized controlled trial for improving effects of "KIMIE WHITE" or "CYSTATHIONE" on skins in women
A randomized controlled trial for improving effects on skins in women
Japan |
Healthy adults
Not applicable | Adult |
Others
NO
To investigate whether the "KIMIE WHITE" or "CYSTATHIONE" improves skins in women.
Efficacy
Confirmatory
Pragmatic
Not applicable
Skin assessment (Robo Skin Analyzer)
+ fluid
+ lipids
+ brightness
+ number of pigmentation
+ area of pigmentation
+ number of pores
+ number of wrinkle
+ total length of wrinkle
+ total area of wrinkle
+ skin texture
Subjective symptoms measured by Likert scales.
Interventional
Parallel
Randomized
Individual
Double blind -all involved are blinded
Placebo
NO
NO
Institution is not considered as adjustment factor.
NO
No need to know
3
Treatment
Medicine | Food |
Duration: 12 weeks
Test material: KIMIE WHITE
6 (three times) tablets per day
Duration: 12 weeks
Test material: CYSTATHIONE
2 capsules per day (940mg/day)
Duration: 12 weeks
Test material: Placebo
2 capsules per day (940mg/day)
40 | years-old | <= |
60 | years-old | > |
Female
a) Women who are between 40 and 59 years old
b) Persons who are bothering about freckles or ephelides on skin
a) Persons who have previous medical history of malignancy, heart failure, or myocardial infarction
b) Patients being treated for at least one of following diseases; atrial fibrillation, cardiac arrhythmia, hepatic disorder, renal disorder, cerebrovascular disorder, rheumatism, diabetes mellitus, dyslipidemia, hypertension, and other chronic disease
c) Persons who take medicines, herbal medicines, or dietary supplements
d) Persons who are allergic to medicines, or foods related to the test material of this trial
e) Persons who have previous medical history of pollinosis
f) Persons who take dietary supplements or enriched foods
g) Pregnant women, lactating women, or women who want to get pregnant during the trial period
h) Persons who have been enrolled in the other clinical trials within last 3 months before the agreement for the participation to this trial
i) Persons who are judged not suitable to participate in this trial by physician.
60
1st name | |
Middle name | |
Last name | Kazuo YAMAMOTO |
ORTHOMEDICO, Inc.
R&D Department
2F Sumitomo Fudosan Korakuen Bldg., 1-4-1 Koishikawa, Bunkyo-ku, Tokyo.
03-3818-0610
kazu@orthomedico.jp
1st name | |
Middle name | |
Last name | Naoko SUZUKI |
ORTHOMEDICO, Inc.
R&D Department
2F Sumitomo Fudosan Korakuen Bldg., 1-4-1 Koishikawa, Bunkyo-ku, Tokyo.
03-3818-0610
nao@orthomedico.jp
ORTHOMEDICO Inc.
JAPANYAKUGEN CO., LTD.
Profit organization
Seishin-kai Medical Association Inc, Takara Medical Clinic.
TOYAMA JOBIYAKU GROUP Inc.
TO PRETTY CO., LTD.
YES
1401-1312-NY02-05-TC
Ethics Committee of Seishin-kai medical association Inc, Takara medical clinic.
広尾皮フ科クリニック (東京都)
Hiroo Dermatology Clinic & Mentors inc. (Tokyo)
2014 | Year | 02 | Month | 14 | Day |
Unpublished
Completed
2014 | Year | 01 | Month | 15 | Day |
2014 | Year | 01 | Month | 16 | Day |
2014 | Year | 05 | Month | 01 | Day |
2014 | Year | 05 | Month | 01 | Day |
2014 | Year | 06 | Month | 01 | Day |
2014 | Year | 06 | Month | 30 | Day |
2014 | Year | 02 | Month | 14 | Day |
2017 | Year | 01 | Month | 30 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000015354